We are intensively involved in plant research and the breeding of the future in order to promote the cultivation and production of highly effective cannabinoids. With our research, we are committed to improving the quality of life for many people. We want make our organically grown ingredients available to patients with chronic and acute issues.


Our core competence lies in the cultivation of hemp flowers with a high content of cannabidiol (CBD). Numerous studies by renowned universities show that CBD can be anti-inflammatory, anti-inflammatory, anti-anxiety and anti-nausea. With the THC content of less than one percent required by law in Switzerland, our CBD products have no psychoactive effect.


We focus on organic farming, sustainability and 100% pure Swiss quality. Through the careful selection of our raw materials and the permanent optimization of our processes, we meet the high requirements of the food and cosmetics industry. In the medium term, our research projects are aimed at producing cannabinoids and other plant active ingredients according to GMP standards for pharmaceutical and medical purposes.


Thanks to our experience and networking in the industry, profound knowledge about the entire value chain of the cannabis industry is united under the roof of GrowArt. We not only act in production and development, but also see ourselves as an interface between producers and consumers, doctors and patients, and researchers and investors. As mediators, we would like to pass on our knowledge and contribute to sustainably improving the wellbeing and quality of life of a broad public.


Lukas Zehnder

CEO – Founder


+41 52 385 58 86